drugset
Drugs / IL15-DC Vaccine
last change Dec 2016 re-read 3 minutes ago

IL15-DC Vaccine

Vaccine

Developed for
metastatic melanoma
Investigated by
Baylor Research Institute · National Cancer Institute (NCI) · National Institutes of Health (NIH)

Trials 1

today NCT01189383 · Ph 1/2
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01189383 Jan 2011 → Dec 2016 metastatic melanoma Baylor Research Institute Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IL15-DC Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01189383 ↗
Modality Vaccine “dendritic cell vaccine” NCT01189383 ↗
Route Subcutaneous “injected (subcutaneously)” NCT01189383 ↗